Control of experimental spasticity by targeting the degradation of endocannabinoids using selective fatty acid amide hydrolase inhibitors. Pryce G, Cabranes A, Fernández-Ruiz J, Bisogno T, Di Marzo V, Long J, Cravatt B, Giovannoni G, Baker D Mult Scler. 2013 Apr 26. PMID: 23625705. Abstract CommentRecommendBookmarkWatch